Clover Health said in a March 4 news release it is the first insurer live on a CMS-aligned network for patient-directed data requests. CMS had labeled other payers "early adopters," but a Clover spokesperson said Clover was the first to fully integrate. In parallel, HHS officials told a Senate subcommittee they are progressing on information-blocking enforcement nearly a decade after Congress banned it. That makes interoperability spend less optional: once members can pull data on demand, plans own the operating cost and the service expectations.

CMS flagged a new DMEPOS enforcement move in its March 5, 2026 MLN Connects newsletter: a temporary enrollment moratorium on medical supply companies. The moratorium blocks new Medicare supplier enrollments where applied, a blunt tool CMS uses when it sees elevated fraud risk. For MA and FFS administrators, fewer new supplier NPIs narrows procurement options and can concentrate volume with incumbent vendors. That may cut exposure to "pop-up" billing, but it can also tighten capacity and trigger higher prices or complaints that flow into MLR and quality.

Grow Therapy raised $150 million to expand enterprise partnerships with physicians and employers, Fierce Healthcare reported. The company said doctors and employers are newer customer types but have driven its growth focus over the past five years. Grow aims to streamline referrals and care coordination across settings, positioning itself as infrastructure rather than just a therapy marketplace. For payers and employer sponsors, tighter referral plumbing can mean higher behavioral utilization with clearer steerage, shifting PMPM assumptions and network management leverage.